Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-05-15
1989-08-01
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514863, A61K 31505
Patent
active
048533882
ABSTRACT:
A method for treating psoriasis comprising applying an effective amount of a cytotoxic drug dispersed in a pharmaceutically acceptable vehicle containing a penetrating solvent for the drug, the drug being applied to the skin area affected by the psoriasis without occlusion in pulses of from 1 to 3 applications per pulse, the pulses being applied at an interval of once every from 3 to 30 days and preferably at an interval of from 4 to 14 days. Optimally, the penetrating solvent is free from toxic effects, such as AZONE or similar substituted azacycloalkyl-2-ones, tertiary amine oxides, and the like.
REFERENCES:
patent: 3989816 (1976-11-01), Rajadhyaksha
patent: 4423040 (1983-12-01), Rajadhyaksha
patent: 4636509 (1987-01-01), Phillipps et al.
patent: 4705791 (1987-11-01), Bemeche et al.
Pearlman et al., J. Am. Acad. Dormatol. vol. 17, No. 1, pp 78-82 (1987).
Pearlman et al. J. Am. Acad. Dermotol. 15:1247-52, 1986.
Peck et al., "Topical Lomustine in the Treatment of Psoriasis." Arch. Derm. 106:172-176 (1972).
Schenkman Leonard
Walker William B.
LandOfFree
Method for treating psoriasis with cytotoxic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating psoriasis with cytotoxic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating psoriasis with cytotoxic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-131696